Regulation & Compliance

Phoenix-based value investor Smead Capital hires a compliance veteran from T. Rowe Price, signaling a strategic move to fortify its framework amid growth.

The investment firm reports a 213% revenue surge after a major acquisition, but a 'going concern' note raises questions about its financial footing.

Delcath Systems is set to showcase its innovative HEPZATO KIT at SIR 2026, signaling growing adoption and a pivotal moment for its targeted cancer therapy.

ERES schedules a vote on a $1.19/unit all-cash offer from CAPREIT, signaling the final step in a multi-year wind-down and a strategic shift for both REITs.

With the appointment of Stephen Gilderdale, Senzing signals its ambition to dominate the critical data trust layer for a new generation of autonomous AI.

Canals' new end-to-end AI platform promises radical efficiency for distributors. But what are the real-world impacts on jobs, data, and integration?

A new investigation shows drug companies make $31 in profit for every $1 paid in penalties, suggesting fines are just a cost of doing business.

auxi AI launches Darwin, an AI agent for consultants and bankers, promising to slash deck-building time and boost strategic depth within PowerPoint.

An AI literacy group used April Fools' Day to launch a stark warning about misinformation, as AI-generated fakes threaten upcoming US and Brazil elections.

As regulators demand PBM reform, Liviniti marks 15 years and 1 million members served with its pioneering transparent, pass-through pricing model.

A new patent-pending system from Escalated.io promises to filter invalid traffic at the source, potentially saving the ad industry billions.

Evolveum unveils midPilot, an AI to fix slow IGA onboarding, as firms flee proprietary tech for open-source control and digital sovereignty.

New research shows AI is deeply embedded in project delivery, but professionals face an urgent need for advanced skills in ethics and data literacy.

A new report reveals why so many expats in Germany feel overwhelmed and isolated, despite most ultimately finding a better quality of life in the end.

Nodal Clear promotes Demetri Karousos to CEO and Huan Zhang to President, signaling a strategic focus on continuity, innovation, and risk management.

A landmark case could strip healthcare giants of a key legal defense, holding them accountable for allegedly deceiving seniors into for-profit Medicare plans.

Securityholders overwhelmingly approve a C$0.90 per share cash offer from Mansa Resources, paving the way for the Dugbe Gold Project's private development.

The American Skin Association launches SKINsight, a podcast series uniting top doctors and patients to demystify skin disease for millions of listeners.

NewBeauty's 16th annual awards spotlight 395 winners, signaling a major shift towards science-backed efficacy and holistic health in the beauty market.

Vlasic Labs announced its CBD products qualify for a landmark Medicare pilot. The problem? Official sources show no record of such a program existing.